Bioelectronics Corp (BIEL)

[Just No]

Speaking of false information.

Actipatch Was Superior To A Cox 2 Opioid Deemed To Strong

There is no such thing as a Cox-2 Opiod.

You seem to be referring to the Cervical Osteoarthritis study.
Pulsed Shortwave Therapy in Cervical Osteoarthritis: an NSAID- Controlled, Randomized Clinical Trial
https://link.springer.com/article/10.1007/s42399-020-00652-y
In that study, they compared ActiPatch to Arcoxia, an NSAID Cox-2 inhibitor not approved for use in the USA. Arcoxia is not an opioid.

They showed that ActiPatch was superior to Arcoxia, so that was good, but as has been pointed out, it doesn’t speak to opioid use specifically.

The argument that if it reduces one type of analgesic, it will work similarly with other types is worth making. Sometimes government agencies are unpredictable.

Does anyone else see the irony in putting so much hope on another government agency providing the impetus needed for BIEL’s success?